ClinConnect ClinConnect Logo
Search / Trial NCT04919538

Longitudinal Study for Relapsing Polychondritis

Launched by UNIVERSITY OF PENNSYLVANIA · Jun 2, 2021

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Rp

ClinConnect Summary

This clinical trial, known as the Longitudinal Study for Relapsing Polychondritis, is focused on understanding a rare condition called relapsing polychondritis (RP). This disease causes repeated inflammation of cartilage in various parts of the body, like the ears, nose, and joints. Sometimes, it can also affect the eyes and skin. The researchers want to learn more about how this condition develops and affects patients over time.

If you or someone you know has been diagnosed with relapsing polychondritis, you may be eligible to participate in this study. The main requirement is having a confirmed diagnosis of RP. The trial is currently looking for participants of all ages and genders. Those who join can expect to share their experiences and health information, which will help researchers better understand this condition. It's important to note that individuals who cannot provide consent or are minors will not be eligible to participate. This study aims to improve knowledge about RP and possibly lead to better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.
  • Exclusion Criteria:
  • 1. Inability to provide consent, or in the case of minors, assent.

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Peter Merkel, MD, MPH

Study Director

University of Pennsylvania

Shubhasree Banerjee, MD

Principal Investigator

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials